Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects()

Prophylactic vaccines for human papillomavirus (HPV) are being introduced in many countries for the prevention of cervical cancer, the second most important cause of cancer-related death in women globally. This is likely to have a significant impact on the future burden of cervical cancer, particula...

Descripción completa

Detalles Bibliográficos
Autores principales: Wigle, Jannah, Coast, Ernestina, Watson-Jones, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763375/
https://www.ncbi.nlm.nih.gov/pubmed/23777956
http://dx.doi.org/10.1016/j.vaccine.2013.06.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763375/
https://www.ncbi.nlm.nih.gov/pubmed/23777956
http://dx.doi.org/10.1016/j.vaccine.2013.06.016

Ejemplares similares